TGen, City of Hope study surveys dysfunctional gene splicing in metastatic kidney disease

Posted on Tue/5/MayTue/5/May by AZBio

AZBio Member Spotlight – Hydrawav3

Posted on Sun/3/MaySun/3/May by Ava Woods

Headquartered in Sedona, Arizona, Hydrawav3 is building a wearable, hands-off recovery platform designed to help practitioners deliver drug-free care to more patients without adding labor or complexity to their workflows.Continue reading→

AZBio Focuses on Purpose During Arizona Tech Week

Posted on Fri/1/MayFri/1/May by AZBio

Continue reading→

J. Craig Venter, genomics pioneer, dies at 79

Posted on Thu/30/AprilSun/3/May by AZBio

La Jolla, California—April 29, 2026—The J. Craig Venter Institute (JCVI) announced that J. Craig Venter, Ph.D., the Institute’s founder, board chair, and chief executive officer, died today in San Diego following a brief hospitalization for unexpected side effects that arose from treatment of recently diagnosed cancer.

Dr. Venter was a visionary scientific leader whose work helped define modern genomics and launch the field of synthetic biology. He drove scientific and technological change by building interdisciplinary teams, pushing for bold ideas and faster methods, and insisting that discovery should translate into real-world impact. He was also a fierce advocate for robust federal science funding and for partnerships that accelerate progress across government, academia, and industry.Continue reading→

7 Health Sciences faculty and staff members receive Convergence Awards

Posted on Wed/29/AprilWed/29/April by AZBio

The annual awards are one of the university’s highest recognitions for interdisciplinary research achievement and honor the faculty, staff and external partners whose work exemplifies the U of A’s commitment to inquiry, innovation and societal impact. The recognition program, which is hosted by the Office of Research and Partnerships, highlights those advancing transformative research and creative activity across disciplines, sectors and communities.Continue reading→

University of Arizona innovation drives $459.7 million in annual economic impact for Arizona

Posted on Tue/28/AprilSat/2/May by AZBio

New independent analysis finds Tech Launch Arizona supported 3,070 jobs in FY 2025 and projects $2.5B more in economic output through 2030.Continue reading→

Critical Path Institute Awards $456,000 Grant to Advance Next-Generation Therapy for Rare Glycolipid Storage Disorders

Posted on Tue/28/AprilTue/28/April by Roxan Olivas

TUCSON, Ariz., April 28, 2026 — Critical Path Institute® (C-Path) today announced a $456,000 grant to James Shayman, M.D., at the University of Michigan, to support development of a brain-penetrant therapy for glycosphingolipid storage disorders. Continue reading→

Jazz Pharmaceuticals Announces FDA Acceptance and Priority Review of Supplemental Biologics License Application for Ziihera® (zanidatamab-hrii) Combinations in First-Line HER2+ Locally Advanced or Metastatic GEA

Posted on Mon/27/AprilSat/2/May by AZBio

Prescription Drug User Fee Act (PDUFA) date set for August 25, 2026Continue reading→

C-Path Podcast Highlights Bold Ideas in Drug Development

Posted on Mon/27/AprilMon/27/April by AZBio

The Critical Path Institute Podcast started connecting the dots for health innovators around the world one year ago. What started as a bold idea to bring the world of drug development, regulatory science, and clinical research to life through conversation has grown into a rich library of episodes covering everything from clinical outcome assessments and pediatric drug development to rare disease research and the power of data collaboration. Continue reading→